日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction: A novel oncolytic Vaccinia virus armed with IL-12 augments antitumor immune responses leading to durable regression in murine models of lung cancer

更正:一种新型溶瘤痘苗病毒携带IL-12,可增强抗肿瘤免疫反应,从而在小鼠肺癌模型中实现持久消退。

Chen, Lijuan; Wang, Pengju; Di Gioia, Carmela; Yuan, Ming; Zhang, Zhe; Miao, Jinxin; Yan, Wenli; Zhao, Guanghao; Jia, Yangyang; Wang, Na; Zhang, Zhongxian; Guo, Haoran; Marelli, Giulia; Dunmall, Louisa Chard; Lemoine, Nicholas R; Wang, Yaohe

The oncolytic adenovirus Ad-TD-nsIL12 in primary or progressive pediatric IDH wild-type diffuse intrinsic pontine glioma results of two phase I clinical trials.

溶瘤腺病毒 Ad-TD-nsIL12 治疗原发性或进展性儿童 IDH 野生型弥漫性内生性脑桥胶质瘤的两项 I 期临床试验结果

Qian Xiao, Ning Weihai, Yang Jingjing, Dunmall Louisa Chard, Pandha Hardev S, Shang Guanjie, Guo Yuduo, Zhang Dongxu, Qu Yanming, Wang Haoran, Gu Chunyu, Zhang Mingshan, Wang Yaohe, Wang Shengdian, Zhang Hongwei

Treatment of intracranial inflammatory myofibroblastic tumor with PD-L1 inhibitor and novel oncolytic adenovirus Ad-TD-nsIL12: a case report and literature review

应用PD-L1抑制剂和新型溶瘤腺病毒Ad-TD-nsIL12治疗颅内炎性肌纤维母细胞瘤:病例报告及文献综述

Qian, Xiao; Ning, Weihai; Dunmall, Louisa Chard; Qu, Yanming; Wang, Yaohe; Zhang, Hongwei

Patient-derived xenograft: a developing tool for screening biomarkers and potential therapeutic targets for human esophageal cancers

患者来源的异种移植:一种用于筛选人类食管癌生物标志物和潜在治疗靶点的新兴工具

Lan, Tianfeng; Xue, Xia; Dunmall, Louisa Chard; Miao, Jinxin; Wang, Yaohe